Where can I learn more about this study?
You can find more information about this study on the websites listed below. When a full report of the study results is available, it also can be found here.

- [clinicaltrials.gov](www.clinicaltrials.gov). Once you are on the website, type "NCT02547922" into the search box and click "Search".
- [clinicaltrialsregister.eu](http://www.clinicaltrialsregister.eu). Once you are on the website, click "Home and Search", then type "2015-001442-29" in the search box and click "Search".
- [AstraZenecaClinicalTrials.com](www.AstraZenecaClinicalTrials.com). Once you are on the website, type "D3461C00007" into the search box, and click "Find a Study".

Full Study Title: A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 2 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Proliferative Lupus Nephritis.

AstraZeneca AB Protocol Number: D3461C00007

National Clinical Trials Number: NCT02547922

EudraCT Number: 2015-001442-29

AstraZeneca AB sponsored this study and has its headquarters in Söderltälje, Sweden.

Thank you!

Clinical study participants belong to a large community of people who take part in clinical research around the world. They help researchers answer important health questions and find medical treatments for patients.

The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants for clinical studies, nor is it involved in conducting clinical studies.

CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | [www.ciscrp.org](www.ciscrp.org)

Version 1.0 2021_10_27